BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 12412982)

  • 1. Vascular endothelial growth factor and proinflammatory cytokines in pleural effusions.
    Momi H; Matsuyama W; Inoue K; Kawabata M; Arimura K; Fukunaga H; Osame M
    Respir Med; 2002 Oct; 96(10):817-22. PubMed ID: 12412982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential diagnosis of tuberculous pleurisy by measurement of cytokine concentrations in pleural effusion.
    Ogawa K; Koga H; Hirakata Y; Tomono K; Tashiro T; Kohno S
    Tuber Lung Dis; 1997; 78(1):29-34. PubMed ID: 9666960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proinflammatory cytokines and fibrinolytic enzymes in tuberculous and malignant pleural effusions.
    Hua CC; Chang LC; Chen YC; Chang SC
    Chest; 1999 Nov; 116(5):1292-6. PubMed ID: 10559090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor in malignant and tuberculous pleural effusions.
    Lim SC; Jung SI; Kim YC; Park KO
    J Korean Med Sci; 2000 Jun; 15(3):279-83. PubMed ID: 10895968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of tumor necrosis factor-alpha, interferon-gamma, interleukin-10 and adenosine deaminase 2 in differential diagnosis between tuberculous pleural effusion and malignant pleural effusion.
    Li M; Wang H; Wang X; Huang J; Wang J; Xi X
    J Cardiothorac Surg; 2014 Jul; 9():118. PubMed ID: 24984978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [VEGF (vascular endothelial growth factor) concentration in serum and pleural fluid of patients with pleural malignancy and pleural tuberculosis].
    Ziora D; Sielska-Spytek E; Dworniczak S; Oklek K; Kozielski J
    Pneumonol Alergol Pol; 2002; 70(9-10):458-67. PubMed ID: 12710098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proinflammatory cytokines, transforming growth factor-beta1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates.
    Chung CL; Chen CH; Sheu JR; Chen YC; Chang SC
    Chest; 2005 Aug; 128(2):690-7. PubMed ID: 16100155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour necrosis factor, interleukin-1 and adenosine deaminase in tuberculous pleural effusion.
    Orphanidou D; Gaga M; Rasidakis A; Dimakou K; Toumbis M; Latsi P; Pandalos J; Christacopoulou J; Jordanoglou J
    Respir Med; 1996 Feb; 90(2):95-8. PubMed ID: 8730328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of vascular endothelial growth factor (VEGF) in neoplastic and tuberculosis effusions--preliminary results].
    Jankowska R; Porebska I; Dyła T
    Pneumonol Alergol Pol; 2002; 70(5-6):258-64. PubMed ID: 12518624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions.
    Duysinx BC; Corhay JL; Hubin L; Nguyen D; Henket M; Louis R
    Respir Med; 2008 Dec; 102(12):1708-14. PubMed ID: 18760578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor level correlates with transforming growth factor-beta isoform levels in pleural effusions.
    Cheng D; Lee YC; Rogers JT; Perkett EA; Moyers JP; Rodriguez RM; Light RW
    Chest; 2000 Dec; 118(6):1747-53. PubMed ID: 11115468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions.
    Zhou WB; Bai M; Jin Y
    Int J Tuberc Lung Dis; 2009 Mar; 13(3):381-6. PubMed ID: 19275801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions.
    Hamed EA; El-Noweihi AM; Mohamed AZ; Mahmoud A
    Respirology; 2004 Mar; 9(1):81-6. PubMed ID: 14982607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superoxide dismutase 2 as a marker to differentiate tuberculous pleural effusions from malignant pleural effusions.
    Wang M; Zhang Z; Wang X
    Clinics (Sao Paulo); 2014; 69(12):799-803. PubMed ID: 25627990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
    Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI
    Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparison of pleural fluid TNF-alpha and IL-10 levels with ADA in tuberculous pleural effusion.
    Ciledag A; Kaya A; Erol S; Sen E; Celik G; Cesur S; Fidan Y; Kinikli S
    Curr Med Chem; 2010; 17(19):2096-100. PubMed ID: 20423308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokines in pleural liquid for diagnosis of tuberculous pleurisy.
    Yamada Y; Nakamura A; Hosoda M; Kato T; Asano T; Tonegawa K; Itoh M
    Respir Med; 2001 Jul; 95(7):577-81. PubMed ID: 11453314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of c-c chemokines in the determination of pleural effusion etiology].
    Trzaska-Sobczak M; Pierzchała W; Brozek G; Farnik M
    Wiad Lek; 2008; 61(7-9):190-4. PubMed ID: 19172830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Significance of Measuring Vascular Endothelial Growth Factor for the Differentiation between Malignant and Tuberculous Pleural Effusion.
    Kim HR; Kim BR; Park RK; Yoon KH; Jeong ET; Hwang KE
    Tohoku J Exp Med; 2017 Jun; 242(2):137-142. PubMed ID: 28626164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proinflammatory and antiinflammatory cytokine levels in complicated and noncomplicated parapneumonic pleural effusions.
    Marchi E; Vargas FS; Acencio MM; Sigrist RMS; Biscaro MDA; Antonangelo L; Teixeira LR; Light RW
    Chest; 2012 Jan; 141(1):183-189. PubMed ID: 21680642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.